Chinese Tourist Stunned By RM1 Injury Treatment At Malaysian Government Clinic
Detailing his experience to Xiaohongshu, a Chinese national tells about his encounter at a Malaysian government clinic where he was able to get treatment for a minor injury for just RM1. He recounts that he had cut his thumb on a vegetable slicer, which prompted it to bleed nonstop and to seek medical assistance fast.
The man explained that he was admittedly nervous to receive a hefty bill, but was later proved wrong as medical staff helped him with care and even pointed out how cute and neat the nurse had bandaged his wound. Explaining further in the comments section, the man explained that his wife was a Malaysian citizen, making him eligible for public healthcare.
'Even though the fees are low, the staff never cut corners. They give their best and treat everyone equally', the man added in his post. He also noted that this was not his first time at a government clinic, but expressed that every time he went, he felt warmth and peace of mind.
Have you ever sought medical attention at a government clinic?
Source: Xiaohongshu
Alyssa Gabrielle contributed to this article
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
5 hours ago
- The Sun
Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland
HONG KONG SAR - Media OutReach Newswire - 1 August 2025 - Cushman & Wakefield, a leading global real estate services firm, today released its Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland report. It is based on in-depth interview surveys we conducted on professionals active in the life sciences sector on the Chinese mainland. The life sciences industry on the Chinese mainland is undergoing a transformative phase, driven by progressive policies, groundbreaking innovations, the emergence of influential life sciences companies, and strategic regional development. This report delves into the latest trends shaping the sector. Policy Landscape – National and Local Catalysts Reforms enacted in 2024-2025 have significantly accelerated sector development. Nationally, China relaxed restrictions on foreign investment in gene and cell therapy and allowed the establishment of wholly foreign-owned hospitals in key cities. Regulatory incentives – such as data protection and marketing exclusivity – have improved market access for innovative drugs. Locally, cities like Beijing, Shanghai, Shenzhen, Guangzhou, and Suzhou are rolling out targeted subsidies, fast-track approvals, and ecosystem-building programmes that directly benefit biotech development. Recent national policy initiatives on the Chinese mainland Industry Innovation and Company Growth Chinese life sciences companies are moving beyond generic drug manufacturing toward innovative therapies. Firms like Akeso, BeiGene, Gracell, and Legend Biotech are now global players, leading in CAR-T, bispecific antibodies, and AI-assisted R&D. These companies are not only commercialising cutting-edge treatments but also attracting international investment and licensing agreements, reinforcing the Chinese mainland's global relevance in life sciences. Real Estate Development and Regional Hubs Innovation hubs such as Suzhou BioBAY, Zhangjiang Hi-Tech Park (Shanghai), and the Bioisland Innovation Centre (Guangdong) are central to regional clustering. These hubs offer end-to-end support, including shared labs, venture capital access, GMP-compliant facilities, and proximity to academic and clinical networks. The rise of second-tier innovation cities like Chengdu and Ningbo further expands growth corridors. The 'R&D + Manufacturing + Service' ecosystem Source: Cushman & Wakefield Research Landlord Perspectives – Evolving Real Estate Models Real estate developers and landlords are adapting to sector-specific requirements through asset-light models, flexible leasing, and high-specification lab and production space. Tier-1 cities face saturation, but central and western regions exhibit healthy demand. Developers are incorporating advanced sustainability and compliance features to meet growing regulatory and ESG expectations, particularly in GMP and cleanroom environments. Digitalisation, environmental policies, and differentiated tenant strategies are shaping performance. Operators now focus on integrated ecosystems with platforms that link tenants to R&D services, policy benefits, and technology partners. Occupier Perspectives – Growth, Innovation, and Challenges Life sciences occupiers are navigating regulatory reform, rising compliance demands, and intensified market competition. Many are localising production and R&D, leveraging regional subsidies, and investing in AI-powered innovation platforms. Occupiers seek flexibility, proximity to talent and infrastructure, and co-located R&D and manufacturing to support accelerated innovation and operational agility. In real estate, demand is strongest for GMP-certified labs, modular production facilities, and shared innovation platforms. Occupiers emphasise location advantages, sustainability certifications (e.g., LEED, WELL), and integration into clusters that enable faster time-to-market. Tony Su, Managing Director, National Head of Industrial & Logistics Property Services, China, said, 'Life sciences business parks on the Chinese mainland demonstrated clear regional differentiation, highlighting opportunities for strategic positioning. While Tier-1 cities saw more moderate performance due to broader macroeconomic factors and abundant supply, core cities in central and western regions recorded healthy occupancy rates, underpinned by strong industrial clustering and increasingly sophisticated ecosystems – contributing to steady growth in asset value.' Johnathan Wei, President, Project & Occupier Services, China, said, 'Several interviewed life sciences companies on the Chinese mainland achieved revenue growth supported by innovative products and favourable policy tailwinds. While overall growth remained modest for many, a select group reported strong performance, highlighting opportunities for differentiation'. Andrew Chan, Managing Director, Head of Valuation & Advisory Services, Greater China, said,' Looking ahead to 2025 and beyond, growth opportunities lie in AI-driven drug discovery, personalised medicine, advanced therapeutics (CGT, RNA), and green-certified facilities. Government policies continue to support innovation through fast-track approvals, rare disease funding, and subsidies aligned with dual-carbon and ESG goals'. Shaun Brodie, Head of Research Content, Greater China, 'Life sciences real estate is shifting from generic parks to specialised, digitally enabled campuses with high compliance and flexibility. Investment strategies increasingly emphasise long-term partnerships, collaborative operating models, and digital infrastructure. Both landlords and occupiers express cautious optimism, with strategic differentiation and regional targeting seen as keys to unlocking future value'. Please click here to download the full report.
Rakyat Post
9 hours ago
- Rakyat Post
Malaysia's Health Crisis: Half The Population Now Overweight
Subscribe to our FREE Malaysia is facing a growing health emergency – one in two adults is now overweight or obese, with the numbers climbing steadily from 44.5% in 2011 to a staggering 54.4% in 2023. The situation is particularly concerning among certain groups, with Indian Malaysians recording the highest obesity rates at 63.9%, followed by women at 54.7%, and those aged 50-59 at 60.9%. But weight isn't the only problem. The latest health data reveals Malaysians are living increasingly sedentary lifestyles – one in three adults gets no physical exercise at all. At the same time, 84% don't participate in sports or use walking or cycling for transportation. The Diet Problem Our eating habits aren't helping either. A shocking 95.1% of Malaysian adults don't eat enough fruits and vegetables daily, consuming only two servings instead of the recommended five. Meanwhile, one in five adults doesn't drink enough plain water. These alarming health statistics were presented at Monash University during a ceremony marking a significant new research partnership. Recognising this health crisis, nutrition company The collaboration, witnessed by Minister of Science, Technology and Innovation, Chang Lih Kang, will study how specific nutrients—including plant proteins, fibre, probiotics, and postbiotics—can improve digestion, reduce inflammation, and strengthen the immune system. CEO Emphasises Mission-Driven Transformation Speaking at the signing ceremony, Jason Leng, General Manager of Amway Malaysia & Brunei, highlighted the urgency of addressing Malaysia's health challenges through scientific innovation. We are here today because non-communicable diseases (NCDs) remain one of the most pressing health challenges in Malaysia. They are rising at an alarming rate, demanding not only lifestyle changes but also stronger scientific understanding and intervention. He emphasised that gut health has evolved from a niche interest to a critical area of study, now recognised as central to managing inflammation, immunity, metabolic function, and even emotional wellbeing. By combining Monash University's scientific expertise with Amway's long-standing investment in nutrition and innovation, it is setting the foundation for research that can truly impact lives by developing solutions tailored to the Malaysian population's gut microbiome and health profile, he explained. Leng also revealed that Amway Malaysia has undergone a significant transformation as it approaches its 50th anniversary next year. 'We have moved from being product providers to being partners in people's wellbeing journeys,' he said, describing it as 'more than a business evolution; it is a mission-driven transformation.' (Pix: Amway) Why Gut Health Matters Scientists now understand that gut health isn't just about digestion – it affects immunity, metabolism, and even mental wellbeing. The research will utilise advanced laboratory models to investigate how specific food combinations can aid in repairing and maintaining a healthy gut barrier. Dr. Chong Chun Wei and Dr. Lim Wei Meng from Monash University will lead the research, examining how targeted nutrition might help prevent and manage lifestyle diseases that are becoming increasingly common in Malaysia. This partnership reflects a growing recognition that Malaysia's health challenges require scientific solutions tailored to local needs. With The research aims to develop evidence-based nutritional strategies that can help Malaysians lead healthier lives, potentially reversing the concerning health trends that have emerged over the past decade. As Malaysia grapples with rising obesity rates and sedentary lifestyles, this scientific collaboration holds promise for developing practical solutions to enhance public health outcomes nationwide. READ MORE : Share your thoughts with us via TRP's . Get more stories like this to your inbox by signing up for our newsletter.
The Star
11 hours ago
- The Star
Amway and Monash University collaborate to tackle gut health and chronic disease
Chang (centre) witnessing the signing of the Master Research Agreement between Anway Malaysia and Monash University Malaysia representatives in Kuala Lumpur. KUALA LUMPUR: In a major step forward for Malaysia's health and wellbeing landscape, Amway Malaysia and Monash University Malaysia have signed a three-year Master Research Agreement (MRA) to advance microbiome science in the fight against non-communicable diseases (NCDs) — a leading cause of death and disability in Malaysia. The pioneering initiative will specifically explore how targeted nutrition can improve gut health and help reduce the risk of chronic lifestyle diseases and NCDs such as obesity, diabetes, heart disease and mood disorders. The gut microbiome plays a vital role in digestion, immunity, metabolism and mental well-being, with NCDs estimated to affect one-third of Malaysians and cause nearly 72% of all premature deaths, making them the leading cause of death and disability in the country. The initiative is closely aligned with the objectives of Malaysia's National Science, Technology and Innovation Policy (NSTIP), which seeks to build a more competitive and socially responsible STI ecosystem. By supporting public health efforts and delivering impactful, community-level solutions, the collaboration reflects NSTIP's core vision of 'Innovation for Well-Being', a commitment to advancing science that brings direct benefits to the people. The signing ceremony was witnessed by the Science, Technology and Innovation Minister Chang Lih Kang. Meanwhile, representing Amway Malaysia at the ceremony was its general manager (Malaysia and Brunei) Jason Leng, while Monash University Malaysia was represented by its vice president (research and development) Prof Datuk Dr Faisal Rafiq Mahamd Adikan. 'This MRA will enable advanced scientific testing and clinical insights to guide the development of future wellness solutions. By combining Monash University's scientific expertise with Amway's long-standing investment in nutrition and innovation, we are setting the foundation for research that can truly impact lives by developing solutions tailored to the Malaysian population's gut microbiome and health profile,' said Leng. Led by Monash University's Dr Chong Chun Wei and Dr Lim Wei Meng, the research will examine how ingredients such as plant protein combinations, fiber combinations, probiotics, postbiotics and phytonutrients affect gut balance, nutrient absorption, inflammation and metabolic health. 'This research applies rigorous scientific methods to uncover how specific nutrients influence the gut microbiome and gut integrity and elucidate related metabolic pathways, with the goal of informing evidence-based strategies to prevent and manage lifestyle diseases,' said Dr Chong. One collaboration study will look at how a mix of soy protein, fiber, probiotics and other gut-friendly ingredients can help improve digestion, support good bacteria, reduce inflammation and strengthen the immune system. At the same time, another study will explore how these ingredients — both on their own and combined — can help keep the gut barrier healthy and support overall metabolism. 'At Amway Malaysia, we have always believed in enabling people to live better, healthier lives. Since our establishment in 1976, our journey has evolved tremendously, from offering basic nutrition solutions to now championing a much more holistic view of health and wellbeing. 'As we approach our 50th anniversary next year, this milestone invites us to reflect on how far we've come. Today, we are proud to be at the forefront of science-backed health innovations. We have moved from being product providers to being partners in people's wellbeing journeys, while empowering lives,' said Leng. For more information on this partnership, visit .
